Skip to main content
logo
Enanta Pharmaceuticals, Inc. (ENTA)
NASDAQ: ENTA · Real-Time Price · USD
11.26
-0.47 (-4.01%)
At close: Jun 5, 2026, 4:00 PM EDT
11.28
+0.02 (0.18%)
After-hours: Jun 5, 2026, 4:15 PM EDT

Enanta Pharmaceuticals Revenue

Enanta Pharmaceuticals had revenue of $17.16M in the quarter ending March 31, 2026, with 14.96% growth. This brings the company's revenue in the last twelve months to $69.21M, up 7.37% year-over-year. In the fiscal year ending September 30, 2025, Enanta Pharmaceuticals had annual revenue of $65.32M, down -3.42%.

Revenue (ttm)
$69.21M
Revenue Growth
+7.37%
P/S Ratio
4.74
Revenue / Employee
$576,775
Employees
120
Market Cap
327.42M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Sep 30, 202565.32M-2.31M-3.42%
Sep 30, 202467.64M-11.57M-14.61%
Sep 30, 202379.20M-6.96M-8.07%
Sep 30, 202286.16M-10.91M-11.24%
Sep 30, 202197.07M-25.40M-20.74%
Sep 30, 2020122.47M-82.72M-40.31%
Sep 30, 2019205.20M-1.43M-0.69%
Sep 30, 2018206.63M103.81M100.97%
Sep 30, 2017102.81M14.55M16.48%
Sep 30, 201688.27M-72.61M-45.13%
Sep 30, 2015160.88M113.14M236.98%
Sep 30, 201447.74M15.69M48.94%
Sep 30, 201332.05M-9.65M-23.15%
Sep 30, 201241.71M-176.00K-0.42%
Sep 30, 201141.88M19.12M83.99%
Sep 30, 201022.76M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
REGENXBIO87.82M
Verastem49.59M
Abeona Therapeutics14.54M
Shattuck Labs1.00M
Artiva Biotherapeutics251.00K
Revenue Rankings

ENTA News

More News